David Smadja: Exploring Endothelial Biology and Hemostasis for Innovation in Patient Care
David Smadja, Professor of Hematology (PU-PH) at Paris Cité University, European Georges Pompidou Hospital, shared a post on LinkedIn:
“I would like to thank the RFHT – Francophone Review of Hemostasis and Thrombosis for the presentation of my team, Team 7 – INSERM UMR-S970 – Paris Cardiovascular Research Center – PARCC.
Our team develops translational research focused on endothelopathy and hemostasis disorders, at the interface between basic, clinical and technological innovation.
Our main areas include:
- Vascular biology and endothelial progenitor cells (ECFCs)
- New approaches to regenerative medicine Alexandre G. Lellouch
- Vascular and thromboinflammatory mechanisms, particularly in COVID-19 and Long COVID
- The pathophysiology of hemostasis diseases and in particular deep vein thrombosis Nicolas Gendron, Isabelle Mahé
- Hemocompatibility of circulatory support devices and artificial hearts
This recognition by the RFTH underlines the collective commitment of our team and our national and international collaborations.
Thank you to all the team members, clinical partners and researchers involved in this work.
In 2026 – on the road to new adventures, new innovations and a defense and promotion of science in the face of fake news, because this is also the responsibility of a researcher in the face of obscurantism!”
Other posts featuring David Smadja on Hemostasis Today.
-
Apr 15, 2026, 11:05Julius Kyei Baffour: Understanding Thrombophilia Testing and Patient Risk
-
Apr 15, 2026, 09:10Shall I Bleed Less with Age? Just 2 Weeks Until the Webinar – EHC
-
Apr 15, 2026, 08:51Moustafa Abdou: Sutimlimab is Transforming Outcomes in Cold Agglutinin Disease
-
Apr 15, 2026, 04:52Ulrich Pecks: Personalized Approaches to VTE Prevention in Pregnant Women with Inherited Thrombophilia
-
Apr 15, 2026, 04:06Brenda Pleasant: Insights from the HFA Symposium on Hemophilia Care
-
Apr 15, 2026, 03:43Lexy Halloran: Addressing Diagnostic Inequities in Women with Chronic Conditions
-
Apr 14, 2026, 17:32Denise M.: Surviving Sepsis 2026 – The Upstream Revolution
-
Apr 14, 2026, 17:23Meghanath Yenni։ What’s New in Acute Ischemic Stroke in 2026
-
Apr 14, 2026, 17:11Phil Spinella: What Dose of TXA for Children With Severe Traumatic Bleeding Should You Use?